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Abstract: 
Fluorescence Correlation Spectroscopy (FCS) is a promising tool to study interactions on a single 
molecule level. The diffusion of fluorescent molecules in and out of the excitation volume of a confocal 
microscope leads to the fluorescence fluctuations that give information on the average number of 
fluorescent molecules present in the excitation volume and their diffusion coefficients. In this context, 
we complexed mRNA into lipoplexes and polyplexes and explored the association/dissociation degree 
of complexes by using gel electrophoresis and FCS. FCS enabled us to measure the association and 
dissociation degree of mRNA-based complexes both in buffer and protein-rich biological fluids such as 
human serum and ascitic fluid, which is a clear advantage over gel electrophoresis that was only 
applicable in protein-free buffer solutions. Furthermore, following the complex stability in buffer and 
biological fluids by FCS assisted to understand how complex characteristics, such as charge ratio and 
strength of mRNA binding, correlated to the transfection efficiency. We found that linear 
polyethyleneimine prevented efficient translation of mRNA, most likely due to a too strong mRNA 
binding,  whereas the lipid based carrier Lipofectamine messengerMAX did succeed in efficient 
release and subsequent translation of mRNA in the cytoplasm of the cells. Overall, FCS is a reliable tool 
for the in depth characterization of mRNA complexes and can help us to find the critical balance 
keeping mRNA bound in complexes in the extracellular environment and efficient intracellular mRNA 
release leading to protein production.   
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1. Introduction 
Nucleic acids have been explored widely in basic research and biomedical applications in the past 
decades. There is a growing interest in the use of mRNA as a potential therapeutic in various medical 
indications, ranging from hereditary or acquired metabolic diseases to regenerative diseases, 
therapeutic cancer vaccination and protein-replacement [1]. Conceptually, mRNA exerts its function 
in the cytoplasmic compartment and does not depend on nuclear envelope breakdown. Also, unlike 
plasmid DNA (pDNA), there is no risk of insertional mutagenesis for mRNA, which provides a substantial 
safety advantage for clinical practice [2][3][4]. In addition, mRNA production is relatively simple and 
low-cost as there is no need to select and incorporate a specific promotor into the transfection 
construct [5].  
To advance protein-replacement therapies [1][6][7][8][9][10], efficient mRNA delivery to the target 
cells is key. In vitro transfection strategies have benefited from the development of formulations to 
protect mRNA from degradation mediated by RNase and to facilitate cellular uptake [11]. In addition 
to the cationic lipids [12][13][14][15][16], other investigated chemical delivery systems include cationic 
polymers, such as polyamidoamine dendrimers and polyethylenimine (PEI).   
Among the various types of non-viral vectors, cationic lipids are especially attractive as they can be 
prepared with relative ease and have been extensively characterized [17][18]. More and more 
commercial non-viral vectors consisting of cationic lipids are available for in vitro mRNA delivery, such 
as Lipofectamine® 2000 and Lipofectamine® messengerMAX [19][20][21]. In contrast, cationic 
polymers are hardly investigated for mRNA delivery, although they have been widely exploited with 
great success for other nucleic acids, such as pDNA, oligonucleotides and siRNA [22]. One of the most 
widely employed cationic polymers is PEI, due to its advantages such as a strong DNA condensation 
capacity and buffer capacity, which provides PEI with some endosomal escape ability (proton sponge 
effect). PEI exists as a linear or branched polymer and can be found with different molecular weights. 
Among them, linear PEI of 22 kDa and branched PEI of 25 kDa are the most effective transfection 
reagents used in vitro and in vivo with pDNA [23][24]. However, high molecular weight PEI also shows 
relatively considerable toxicity, whereas PEI with low molecular weight has low toxicity but less 
transfection efficiency. It has been reported that PEI polymers are able to efficiently complex and thus 
protect unmodified RNA molecules including ribozymes and siRNAs [25]. Only few studies addressed 
PEI for mRNA delivery, where it was typically less effective [22], potentially due to differences in mRNA-
polycation binding compared to pDNA and siRNA [26][27][28][29].  
Both cationic polymers and cationic lipids face barriers to gene delivery [30]. The mRNA delivery 
systems should have high transfection efficiency, low cytotoxicity and no immune response [31]. Also, 
it should achieve a sufficiently high level of the encoded protein and reach a high number of cells. In 
most transfection studies, complexes are administered to cells in a reduced serum condition such as 
Opti-MEM when evaluating their stability, uptake, intracellular trafficking and transfection. It is well-
established, however, that once in contact with protein-rich biological fluids, most nanoparticles are 
spontaneously covered by a layer of biomolecules with the formation of a so-called “protein corona” 
[32][33][34]. This corona might seriously affect the performance of complexes, both on the level of 
extracellular stability, cell targeting, cellular uptake and intracellular trafficking [35][36]. Therefore, 
performing in vitro optimization of nano-sized formulations in undiluted biological fluids before 
assessing the functionality in vivo is always advised [37]. Clearly, a good delivery system should 
maintain a critical balance between complexing the mRNA in the extracellular environment, but 
releasing it inside the cytoplasm of the cells. The association and dissociation from mRNA to a certain 
carrier is mostly investigated by gel electrophoresis. This analytical tool, however, is not applicable to 
explore the stability and integrity of mRNA-carrier complexes in biological fluids, as proteins and 
nucleic acids in the biological fluid interfere with the read-out of the gels [26][27][28][29][38][39][40].  
Our research group has reported before that FCS is a valuable tool to explore the delivery of short 
antisense oligonucleotides and siRNA (21 nucleotides) with lipid-based and polymer-based carriers: 
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both the protection of the nucleic acids against enzymatic degradation and the association and 
dissociation of the nucleic acids from the carriers can be followed in buffer, in biological fluids such as 
human serum and intraperitoneal fluids and inside living cells [41][42][43]. The applicability of FCS to 
explore complex characteristics between carriers and much longer nucleic acids such as mRNA (1000 
nucleotides), however, has not been reported before. In the present study, we aimed to evaluate 
whether FCS can be used to explore the stability of mRNA-complexes in buffer and in biological fluids. 
Lipofectamine messengerMAX and linear PEI were chosen as representative lipid- and polymer-based 
carriers to complex mRNA into lipoplexes and polyplexes, respectively. We found that FCS is able to 
measure the degree of association and dissociation of mRNA-based complexes in buffer, full human 
serum and human ascitic fluid in a few minutes, while gel electrophoresis resulted in reliable 
measurements only in buffer. Furthermore, we evaluated the transfection efficiency of the mRNA-
complexes in low-protein and high-protein conditions and attempted to correlate the results with 
differences in mRNA binding and release, as determined by FCS. The lipid-based carrier used in this 
study was more efficient when compared to linear PEI that failed to release the complexed mRNA in 
the cytoplasm of the cells. Therefore, a critical balance should be maintained between complexing the 
mRNA in the extracellular environment, without compromising the ability of the carrier to release its 
cargo into the cytoplasm of the cells.    
2. Materials & Methods 
2.1 Consumables 
Lipofectamine® MessengerMAX and linear jetPEI (average Mw 22kDa) were purchased from Invitrogen 
(Merelbeke, Belgium) and Polyplus-transfection® SA (Strasbourg, France), respectively. mRNA 
encoding GFP labeled by Cyanine 5 (ARCA capped, 25% Cyanine 5-U, 75% Pseudo-U, 100% 5-Me-C) 
was purchased from Trilink (California, USA). HEPES, sucrose, sodium dodecyl sulfate and dextran 
sulfate with Mw’s of 50 kDa were purchased from Sigma-Aldrich (Belgium). Mccoy’s 5A modified 
Medium, Opti-MEM, 0.25% Trypsin-EDTA (1×), penicillin-streptomycin (5000 U/ml) and DPBS [-] (no 
calcium, no magnesium) were purchased from Invitrogen (Merelbeke, Belgium).  
2.2 Collection of biological fluids 
Human serum was obtained from healthy volunteers. Blood was collected into VenosafeTM 6 ml tubes 
containing gel and clotting activator (Terumo EuropeTM, Leuven, Belgium) at Ghent University hospital. 
Then the tubes were centrifuged for 10 minutes with a speed of 4000× g at 20°C. The supernatant 
(serum) was aliquoted (50 μl) in sterile polypropylene tubes and stored at -20°C and thawed at 4°C 
overnight prior to use. Human ascitic fluid was obtained from patients diagnosed with peritoneal 
carcinomatosis at the department of medical oncology, Ghent University hospital, with approval of the 
ethics committee of the Ghent University hospital (ECD no. 2013/589).  
2.3 Association degree (%) of complexes in HEPES buffer measured by gel electrophoresis and FCS  
To study the complexation of mRNA and linear PEI (linPEI) by agarose gel electrophoresis and FCS, 5 μl 
PEI solution (the concentration of PEI depending on the desired N/P ratio of 0, 0.25, 0.5, 1, 2, 5, 10, 15, 
20, 30) was added to 5 μl mRNA (80 μg/ml), vortexed for 15 s and incubated at room temperature for 
30 min prior to use. messengerMAX/mRNA complexes were prepared as following: messengerMAX 
solution (the volume depending on the desired v/w ratio (volume (µl)/weight(µg)), namely 0, 0.25, 0.5, 
1, 2, 3, 5, 10) was mixed with HEPES buffer (pH7.4, 20 mM) to a total volume of 5 μl and incubated at 
room temperature for 10 min prior to use. Then, 5 μl of the messengerMAX solution was added to 5 
μl mRNA (80 μg/ml) and mixed well, followed by incubation at room temperature for 30 min. After 
incubation, 20 μl HEPES buffer (pH7.4, 20 mM) was added to the different complexes to result in 30 µl 
of complex solution.  
For gel electrophoresis, 11.3 μl of this solution was diluted with HEPES buffer (pH7.4, 20 mM) to a total 
volume of 25 μl and loaded on a 1% agarose gel after addition of 5 μl of 50% sucrose. The gel was run 
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for 30 min at 100 V before imaging. The association degree of mRNA was calculated by measuring the 
amount of free mRNA on the gel with Image J. For FCS measurements, the remaining complex solution 
(18.7 μl) was diluted with HEPES buffer (pH7.4, 20 mM) to a total volume of 50 μl.  
2.4 Dissociation degree (%) of complexes in HEPES buffer measured by gel electrophoresis and FCS 
10 μl complex solution was prepared as described above (linPEI/mRNA with N/P ratio of 5, and 
messengerMAX/mRNA with v/w ratio of 3). At the end of incubation, increasing amounts of sodium 
dodecyl sulfate (SDS) and dextran sulfate (DS) were added to 10 μl of lipoplexes and polyplexes, 
respectively. Then the mixture was diluted with HEPES buffer (pH7.4, 20 mM) to a total volume of 30 
μl and incubated at room temperature for 10 min. For gel electrophoresis, 11.3 μl of this solution was 
diluted with HEPES buffer (pH7.4, 20 mM) to a total volume of 25 μl and loaded on the 1% agarose gel 
after addition of 5 μl of 50% sucrose. The gel was run for 30 min at 100 V before imaging. For FCS 
measurements, the remaining complex solution (18.7 μl) was diluted with HEPES buffer (pH7.4, 20 
mM) to a total volume of 50 μl.   
2.5 Complex stability in biological fluids and cell lysate measured by gel electrophoresis and FCS 
14 μl complex solution (i.e. messengerMAX/mRNA with v/w ratio of 1, 3, and 5, linPEI/mRNA with N/P 
ratio of 1, 5 and 10) was prepared by mixing an equal volume of mRNA (200 μg/ml) and messengerMAX 
and linPEI, respectively. For gel electrophoresis, 2.5 μl of this complex solution was added to 22.5 μl 
HEPES buffer (pH7.4, 20 mM), human serum, human ascitic fluid or cell lysate respectively and 
incubated at 37°C for 1 h. Then, the samples were loaded on 1% agarose gel after the addition of 5 μl 
of 50% sucrose. For FCS measurements, 8 μl of the complex solution was diluted with 8 μl HEPES buffer. 
5 μl of this diluted complex solution was mixed with 45 μl HEPES buffer (pH7.4, 20 mM), human serum, 
human ascitic fluid or cell lysate, respectively, and incubated for 1 h at 37°C prior to measurement. Cell 
lysate was prepared by resuspending a cell pellet of SKOV-3 cells (150000 cells/well) in 1 ml RIPA buffer 
(Sigma-Aldrich, Belgium). After 30 minutes incubation on ice, cells were crushed by pipetting up and 
down using 21G needles.  The cell lysate was kept at -80°C until use.  
2.6 Charge and size characterization of mRNA complexes 
 The average size and ζ potential of lipoplexes with varying  v/w ratios and polyplexes with varying N/P 
ratios was measured using Zetasizer Nano-ZS (Malvern, Worcestershire, UK) in HEPES buffer. 
Complexes were allowed to form during 30 minutes at room temperature, after which they were 
diluted with 20 mM HEPES buffer (pH7.4) to a final concentration of 0.3 μg/ml mRNA. All 
measurements are shown in Supplementary Figure 1. Both lipoplexes and polyplexes varied between 
300 and 600 nm and were negatively charged for all tested ratios.   
2.7 Cell culture 
The human ovarian cancer cell line SKOV-3 was used for in vitro experiments. SKOV-3 cells were 
cultured in McCoy’s 5A medium supplemented with 10% Fetal Bovine Serum (FBS) and penicillin-
streptomycin. Cells with 80%-90% confluency were detached from the bottom of the cell culture flask 
with 0.25% trypsin/EDTA. Cells were maintained in an incubator at 37°C in a humidified atmosphere 
containing 5% CO2. 
2.8 Cellular uptake and transfection 
SKOV-3 cells (50 000 cells/well) were cultured in 24-well plates at 37°C, 5% CO2 for 24 h before 
treatment. Before incubation with complexes, cells were washed with DPBS [-] (500 μl/well) and 
cultured with 440 μl Opti-MEM for each well except for the control group which contained 500 μl 
culture medium. Complexes were added to Opti-MEM, human serum or human ascitic fluid to a final 
concentration of 80% biological fluids and pre-incubated at 37°C for 1 h. At the end of pre-incubation, 
60 μl mixture containing 0.3 μg mRNA was incubated with SKOV-3 cells in each well for 4 h for uptake 
and 24 h for transfection at 37°C, 5% CO2, respectively. After 4 h or 24 h incubation, cells were rinsed 
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with DPBS [-] (500μl/well), trypsinized (trypsin/EDTA 0.25%) and diluted with culture medium. 
Following centrifugation (5 min, 500 g), the cell pellet was resuspended in 300 μl flow buffer (PBS 
supplemented with 1% BSA and 0.1% sodium azide) and placed on ice until flow cytometry analysis. A 
minimum of 5 000 cells were analyzed in each measurement by using a flow cytometry (FACSCalibur, 
BD Biosciences Benelux N.V., Erembodegem, Belgium).    
2.9 Cell viability assay 
The MTT assay was used to examine the cell viability following incubation of the studied formulations 
as well as the carriers. SKOV-3 cells (50 000 cells/well) were cultured in 24-well plates at 37°C in a 
humidified atmosphere containing 5% CO2 for 24 h before treatment. Cells incubated with culture 
medium and 70% ethanol (in culture medium) were used as negative (alive) and positive (dead) 
control, respectively. Other cells were incubated with 60 μl complexes or solution only containing 
carriers at 37°C, 5% CO2 for 4 h. Afterwards, the cells were washed with DPBS [-] (500 μl/well), and 
fresh culture medium was added for overnight incubation. After 24 h incubation, 500 μl MTT (1 mg/ml) 
was added to the cells in every well and incubated at 37°C, 5% CO2 for 3 h. At the end of incubation, 
the MTT solution was aspirated and 500 μl DMSO was added to each well to dissolve the formazan 
crystals. The plates were covered with aluminum foil and placed on an orbital shaker for 30 min with 
100 rpm. The absorbance of the formed formazan crystals at 560 nm and 650 nm was measured using 
a Wallac EnvisionTM multilabel reader (PerkinElmer, Zaventem, Belgium). Cell viability (%) for each 
sample was calculated as follows:  
 
𝑐𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
(𝐴𝐸 − 𝐴𝐶)
(𝐴𝑁 − 𝐴𝐶)
× 100% 
where AE, AN and AC are the absorbance of experimental groups, negative groups and positive groups 
(i.e. control groups) respectively.  
2.10 Image J analysis 
To analyze the images obtained from gel electrophoresis by Image J, identical rectangular areas were 
selected for each well at the level of intact mRNA (determined with the free mRNA control). The 
fluorescence intensity of each rectangular area was quantified by the software, corresponding to the 
amount of free mRNA. Then the association or dissociation degree (%) was calculated in relation to the 
control free mRNA.  
2.11 Fluorescence Correlation Spectroscopy (FCS) 
The association and dissociation of fluorescently labeled mRNA to non-labeled carriers in buffer and 
biological fluids was studied by single-color FCS. FCS is a fluorescence microscopy based technique to 
measure the continuous movement of fluorescent single molecules in and out of the detection volume, 
which induces fluorescence fluctuations [43][44][45][46][47]. Fluorescence time traces were obtained 
by focusing a 640 nm laser line through a water immersion objective lens (60x Plan Apo VC, N.A. 1.2, 
Nikon, Japan) at about 50 µm above the bottom of the glass-bottom 96-well plate (Grainer Bio-one, 
Frickenhausen, Germany), which contained the samples (50 µl). The use of a confocal microscope 
(Nikon C1) ensured only the fluorescent light coming from a small volume (by calibration with a 
rhodamine green fluorophore, about 1.9 µm in height and a half width of 0.2 µm)  was collected. The 
fluorescence signal was recorded by a photon counting instrument (PicoHarp 300, PicoQuant). A time 
trace was obtained by binning the photon counts in intervals of 60 s. The fluorescence baseline of the 
time trace was calculated from the empirical fluorescence distribution as the fluorescence value at 
which the distribution is rejected by the Lilliefors test for normality (95% confidence interval). The 
fluorescence baseline of each mixture (Figure 1A, naked mRNA; Figure 1B, mRNA complex) was 
corrected for any background by subtracting the background fluorescence of a blank sample (Figure 
1C, background-C) and a relative baseline is obtained by dividing the fluorescence baseline by the 
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fluorescence baseline of free mRNA at the same concentration. This relative baseline is directly 
proportional to the fraction of free mRNA and serves as a measure for the association/dissociation 
degree of the complexes, as Figure 1 shows. 
 
2.12 Statistical analysis 
Results are shown as mean ± standard deviation. Experiments were performed at least in triplicate on 
independent days. Significance between the means of two groups was tested using 2-way ANOVA with 
the software GraphPad Prism 7. A P-value < 0.05 was considered to be significant. 
 
3. Results and discussion 
3.1 FCS can determine the association degree (%) of mRNA-complexes in HEPES buffer 
Figure 2 shows the association of mRNA with the lipid-based carrier messengerMAX, as followed by 
gel electrophoresis and FCS. From the gel (Figure 2A), it is clear that full complexation of the mRNA 
starts from v/w ratio 3, as naked mRNA is no longer detected on the gel. Using FCS, full complexation 
is confirmed (Figure 2C). Indeed, while naked mRNA results in fluorescence fluctuations around an 
average of 200 kHz (Figure 2B, red line), highly intense fluorescence peaks appear in the fluctuation 
profiles of the complexes at v/w ratio 3 (Figure 2B, blue line), corresponding to highly fluorescent 
complexes which contain multiple mRNA molecules per complex. Also, the fluorescence baseline 
dropped from 207±27 kHz (~100% naked mRNA) to 16±5 kHz (~7% of naked mRNA), upon 
complexation. As the baseline fluorescence correlates with the fraction of remaining naked mRNA, this 
drop again shows the binding of the mRNA to the messengerMAX. Analyzing the association degree 
based on this drop of the fluorescence baseline shows that FCS is equally accurate when compared to 
gel electrophoresis to determine the amount of associated mRNA (Figure 2C). Furthermore, the height 
and the broadness of the peaks in the FCS profiles give extra insight on the complex characteristics. 
Figure 2D, for example, demonstrates that upon increasing the v/w ratio from 3 to 10, the fluorescence 
baseline remains low, but fluorescence peaks become less intense. This suggests that a lower amount 
of mRNA molecules is present per complex, in agreement with the expectation that the mRNA 
molecules can distribute over more messengerMAX/mRNA complexes when a higher v/w ratio is used.    
Apart from the lipid-based carrier messengerMAX, also the widely used polymeric carrier linear PEI 
was followed by gel electrophoresis and FCS. For linPEI, diffusion of naked mRNA into the agarose gel 
is no longer observed from lane 5 (N/P ratio 3), as indicated by the arrow in Figure 3A. When these 
samples were analyzed with FCS, again the fluorescence baseline dropped in comparison with naked 
mRNA (Figure 3B, red line), demonstrating mRNA was complexed. Remarkably, however, highly 
intense fluorescence peaks do not appear in the fluctuation profiles (Figure 3B, blue line). This indicates 
that linPEI strongly condenses the mRNA molecules, thereby quenching their fluorescence and making 
the complexes invisible for the FCS detectors. From the drop of fluorescence baseline, however, the 
association degree of mRNA to linPEI can be calculated in function of the N/P ratio. Also from the gels, 
the amount of complexed mRNA was calculated with Image J. Figure 3C shows that for linPEI up until 
N/P ratio 15, both gel electrophoresis and FCS show the same trend for the calculated association 
degree. A decrease in complexation efficiency seems to occur, however, with higher N/P ratios when 
calculated by FCS, while the agarose gel still shows full complexation. An explanation for this 
phenomenon can be found by analyzing the fluorescence fluctuation profiles of linPEI at higher N/P 
ratios (Figure 3D). First, the fluorescence baseline gradually increases with increasing N/P ratios. 
Second, fluorescence peaks appear in the fluctuation profiles only at higher N/P ratios. These 
observations suggest that mRNA fluorescence is quenched in the complexes at lower N/P ratios, but 
gradually recovers by increasing the N/P ratio. Therefore, this dequenching and corresponding 
increase in baseline fluorescence represents the mRNA distribution over more PEI complexes and not 
an actual decomplexation of mRNA at higher N/P ratios.  
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3.2 mRNA dissociation from lipid- and polymer-based complexes 
The dissociation of mRNA from complexes is essential to obtain free mRNA that is translated into 
proteins in the cytoplasm of the cells [48]. The mRNA dissociation from the lipid based 
messengerMAX/mRNA complexes was investigated by gel electrophoresis and FCS after the addition 
of the surfactant sodium dodecyl sulfate (SDS), which induces the release of mRNA by dissolving the 
lipoplexes. Gel electrophoresis clearly demonstrates the gradual release of mRNA with increasing 
amounts of SDS, reaching full dissociation with 10 μg SDS per 0.4 μg messengerMAX/mRNA complexes 
(Figure 4A). Also FCS was able to follow the dissociation of mRNA in function of the SDS amount by a 
gradual increase in the baseline of the fluorescence fluctuations upon the release of mRNA from the 
complexes, accompanied with a decrease in the amount of fluorescence peaks in the fluorescence 
fluctuations profiles (Figure 4B, D).  
To dissociate the mRNA from the PEI-based complexes, negatively charged dextran sulfate (DS) was 
added to the polyplex dispersions to compete with mRNA for binding to the PEI. As Figure 5A 
demonstrated, (partial) dissociation of mRNA from the complexes was indeed observed by agarose gel 
electrophoresis. Release of mRNA from linPEI started from sample 2 containing 5 μg DS, with about 
60% of mRNA released (Figure 5C). The maximal percentage of released mRNA (around 80%) was 
reached at 10 μg DS (lane 4), followed by a gradual decrease until 200 μg of DS.  
3.3 Stability of mRNA-complexes in undiluted biological fluids and cell lysate 
Biological fluids, such as human serum and human ascitic fluid, contain several negatively charged 
molecules (e.g. albumin) that might compete with mRNA binding to positively charged carriers. 
Therefore, the ability of complexes to retain the complexed mRNA in the presence of human serum 
and human ascitic fluid was evaluated by agarose gel electrophoresis and FCS (Figure 6). As a 
comparison, the amount of complexed mRNA in HEPES buffer is also depicted. Gel electrophoresis 
clearly shows that the biofluids themselves give a background signal on the agarose gel, resulting in a 
huge smear on the gel, probably due the presence of proteins, DNA or RNA in the serum and human 
ascitic fluid (Figure 6A, B, lane 10 and 15)[45]. Also, naked mRNA can no longer be detected on the gel 
in the presence of biofluids. As a consequence, gel electrophoresis is no longer suited to quantify the 
mRNA complexation efficiency in the presence of serum and human ascitic fluid.  
When analyzing the same samples by FCS, the shortcomings of gel electrophoresis could be overcome 
as FCS was able to quantify the amount of free mRNA in mRNA-carrier dispersions, even in the 
presence of biological fluids. This results from the fact that FCS only detects the fluorescent mRNA, so 
that the presence of proteins and other macromolecules does not interfere with the readout of the 
fluorescence fluctuations. It should be noted that naked mRNA is degraded in the presence of biofluids, 
resulting in an increase of the fluorescence intensity of free mRNA (Supplementary Figure 2). As also 
the mRNA released from complexes is degraded, however, this does not interfere with the calculation 
of complex efficiency based on FCS measurements. Figure 6C and 6D demonstrate that the incubation 
of mRNA complexes in biological fluids induces a partial dissociation of the mRNA from the complexes. 
In general, human ascitic fluid displaced more mRNA molecules from the complexes than human 
serum, especially for complexes with a suboptimal carrier/mRNA ratio, while increasing the 
carrier/mRNA ratio makes the complexes more resistant against both human serum and human ascitic 
fluid. Also, the linPEI/mRNA complexes release more mRNA in ascitic fluid when compared to 
messengerMAX/mRNA, especially for the highest ratios (N/P ratio 10 and v/w ratio 5, respectively). To 
estimate the ability of complexes to release mRNA in the intracellular environment, we have 
performed stability measurements of complexes in cell lysate. LinPEI/mRNA with N/P 5 and 10 only 
released about 5% of mRNA after incubation in cell lysate at 37°C for 1 hr, while around 50% and 30% 
of mRNA released from lipoplexes with v/w 3 and 5, respectively. Therefore, it seems that linPEI/mRNA 
complexes are less stable in the extracellular biofluids, but more stable in the intracellular 
environment.   
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3.4 Intracellular mRNA delivery is less productive for PEI based complexes when compared to 
messengerMAX       
To evaluate the cellular entry and transfection properties of complexes, Cy5 (red fluorescence) labeled 
mRNA encoding for enhanced green fluorescence protein (GFP, green fluorescence) was used. The 
uptake of complexes was followed after 4 hours of incubation with the cells, while the expressed GFP 
signal was studied after 24 h. All complexes used did not exhibit any severe decrease in the cell viability 
(Supplementary Figure 3).   
Figure 7 shows the uptake and transfection efficiency obtained for messengerMAX/mRNA and 
linPEI/mRNA complexes in Opti-MEM. Cellular entry is the first important step in the transfection 
pathway. Figure 7 shows uptake in almost 100% of the cells, irrespective of the carrier/mRNA ratio or 
the type of carrier that was used (Figure 7A, D, Cy5). The mean fluorescence intensity (MFI) of Cy5 per 
cell, however, did vary with the type of carrier. Complexes of messengerMAX/mRNA with v/w ratio 3 
and 5 resulted in a MFI around 7000 (Figure 7B, Cy5), while for linPEI/mRNA prepared at N/P ratio 5 
and 10, the amount of mRNA delivered to each cell seems lower, with a MFI around 3500 (Figure 7E, 
Cy5). It should be noted, however that this MFI might be an underestimation due to the quenching of 
Cy5 fluorescence in linPEI/mRNA complexes. MFI of Cy5 in the cells transfected with 
messengerMAX/mRNA (v/w ratio 1) and linPEI/mRNA (N/P ratio 1) at suboptimal ratios was around 
3000 and 1000, respectively, which is much lower than that of analogues with higher carrier/mRNA 
ratios (P=0.0063, **; P<0.0001, ****). As flow cytometry only measures the overall Cy5 fluorescence, 
irrespective of the cellular compartment in which the Cy5-labeled mRNA is present, we additionally 
performed FCS measurements in the cytoplasm of the cells transfected by carriers with an 
intermediate ratio. As Supplementary Figure 4 demonstrates, messengerMAX/mRNA complexes 
deliver on average 10 times more mRNA to the cytoplasm when compared to linPEI/mRNA complexes 
at the 4 hour time point. Also, GFP expression can already be detected in all cells treated with 
messengerMAX/mRNA complexes, while it remains at background level for cells treated with 
linPEI/mRNA complexes. This indicates mRNA is more efficiently delivered to the cytoplasm of the cells 
when messengerMAX/mRNA complexes are used.       
The ability of the internalized mRNA to induce GFP expression was additionally determined after 24 h 
by flow cytometry. Around 93% of the cells transfected with messengerMAX showed expression of the 
GFP, demonstrating the delivery of free mRNA into the cytoplasm of the cells (Figure 7A, GFP). The 
MFI, however, clearly demonstrates that the intermediate carrier/mRNA ratio 3 results in the higher 
amount of GFP expression per cell (Figure 7B, GFP, gray bars), indicating that the release of mRNA in 
the cytoplasm of the cell was more optimal for this carrier/mRNA ratio. For linPEI/mRNA complexes, 
GFP expression was seen in about 65% of the cells treated with N/P ratio 5 and 10 (Figure 7D, GFP), 
which was significantly higher than that of polyplexes with N/P 1 (P<0.0001, ***). Again, the MFI of 
GFP was slightly higher for complexes with the intermediate N/P ratio 5, when compared to those with 
a N/P ratio 1 and 10, although the MFI per cell was clearly much lower when compared to 
messengerMAX. The difference between the lipids- and polymer-based mRNA delivery is also clearly 
visible from Figure 7C, F. Indeed, the GFP fluorescence intensity of cells transfected with 
messengerMAX/mRNA complexes clearly outperforms those from linPEI/mRNA complexes, even 
though the cellular entry of Cy5 labeled mRNA is visible as intracellular red fluorescent dots. Taken 
together, these data demonstrate that the amount of mRNA delivered per cell is comparable for the 
lipid-based messengerMAX and polymer-based linPEI-complexes, but is much more efficiently 
transcribed into GFP when messengerMAX is used, both at the 4 h and 24 h time point.   
3.5 Biofluids decrease uptake and transfection efficiency of PEI based complexes but not of 
messengerMAX 
Considering the fact that in vivo, the complexes for IV or IP administration can come into contact with 
human serum and human ascitic fluid, we also evaluated whether a 1 h pre-incubation of the 
complexes in the biological fluids would influence their uptake and transfection efficiency (Figure 8). 
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The pre-incubation with biofluids does not significantly lower the uptake or transfection efficiency of 
the messengerMAX complexes with v/w 3 and 5, when compared to Figure 7A, B. Again about 100% 
of the cells internalize mRNA (Figure 8A, C, Cy5), with a MFI comparable to the one obtained in Opti-
MEM (Figure 8B, D, Cy5). More than 90% of the complexes express GFP in the presence of the biofluids 
(Figure 8A, C, GFP), and the v/w ratio 3 is most effectively translated into the GFP protein (Figure, 8B, 
D, GFP, grey bars). For linPEI/mRNA complexes, the presence of human serum and human ascitic fluid, 
does not influence the number of Cy5 positive cells when compared to Opti-MEM (Figure 8E, G, Cy5), 
but clearly lowers the amount of mRNA delivered per cell (Figure 8F, H, Cy5). When looking at the GFP 
expression, however, the drastic effect of both human serum and ascitic fluid becomes evident as both 
the percentage of transfected cells (Figure 8E, G, GFP) and the MFI per cell (Figure 8F, H, GFP) 
decreased to background levels (<1%) in the presence of the biofluids. These results correspond to the 
lower stability of linPEI/mRNA complexes in biofluids when compared to messengerMAX/mRNA 
complexes, as observed in Figure 6.  
4. Discussion 
Nucleic acids (including DNA, oligonucleotides, siRNA,  shRNA, mRNA...) have been loaded on vectors 
as therapeutics for various diseases. Vectors, like cationic lipids and cationic polymers, can not only 
transport nucleic acids to the target cells, but also protect nucleic acids from degradation mediated by 
enzymes present in the extracellular and intracellular environment. To obtain an efficient delivery 
system of nucleic acids-based therapeutics, a critical balance between complexing the nucleic acids in 
the extracellular environment and releasing functional nucleic acids into the cytoplasm or nucleus of 
the target cells is required. The most typical method to evaluate the stability of complexes, is gel 
electrophoresis. This method, however, does not allow to study the stability of complexes in biological 
fluids since the background signal and nuclease activity interferes with the readout of the gel. 
Previously, we showed that FCS is a good method to follow stability of siRNA and oligonucleotide 
containing complexes in buffer, biofluids and living cells [41][49]. In this paper, we demonstrated that 
FCS is also applicable to follow the association and dissociation of larger nucleic acids such as mRNA to 
lipid- and polymer-based carriers. The read-out can be performed within minutes without the need to 
separate non-encapsulated mRNA from the complexed fraction. Also, as FCS only detects the 
fluorescently labeled mRNA of interest, there is no interference from mRNA or other nucleic acids 
present in biofluids.    
In this study, mRNA was loaded on a positively charged lipid vector (i.e. messengerMAX) or complexed 
with positively charged polymers (i.e. linPEI). Lipoplexes of messengerMAX/mRNA showed full 
complexation starting from v/w ratio 3 (Figure 2). The presence of complexes was evident from the 
appearance of fluorescence peaks in the fluctuations profiles, as several fluorescently labeled mRNA 
molecules are present in a single complex. This is in agreement with our previous observations when 
complexing fluorescently labeled oligonucleotides or siRNA to DOTAP/DOPE liposomes [41][50]. Also 
in agreement with previous observations, SDS was able to dissociate the mRNA from the complexes. 
When the messengerMAX/mRNA complexes were incubated in biofluids, more than 50% of the 
encapsulated mRNA was released in case of v/w ratio 1 and 3, while this was only 10% for v/w ratio 5. 
Clearly, increasing the v/w ratio of messengerMAX/mRNA thus increased the resistance against 
biofluids. This suggests that at higher complexation ratios, mRNA is mainly encapsulated in the 
lipoplexes’ core, while for low or intermediate ratios, half of the complexed mRNA is loosely attached 
to the surface of the lipoplexes, accessible to competing nucleic acids and macromolecules in the 
biofluids. Transfection experiments demonstrated that the complexes of v/w ratio 3 showed the higher 
GFP expression level per cell when compared to v/w ratio 1 (P=0.0021, **) and 5 (P=0.0019, **). It is 
well accepted that cationic lipoplexes enter cells by endocytosis, followed by endosomal escape. 
Typically, the endosomal escape mechanism that is proposed for lipoplexes is a fusion of the 
phospholipid bilayer of a liposome with the endosomal membrane. Anionic lipids from the inner face 
of the endosomal membrane can interact with the cationic lipids from the lipoplexes to form 
neutralized ion-pairs, allowing cargo release in the cytoplasm during endosomal escape [51]. For 
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messengerMAX/mRNA complexes, with almost 100% of cellular uptake, a comparable amount of 
mRNA complexes was transported into cells for v/w ratio 3 and 5 (Figure 7B). For v/w ratio 5, however, 
the amount of free mRNA that reaches the cytoplasm is apparently less when compared to the 
analogues with v/w ratio 3 as can be seen by the lower amount of GFP expression in Figure 7B although 
no significant differences were observed on the level of cellular entry. Possibly, v/w ratio 5 more 
strongly complexes the mRNA, preventing the efficient release of mRNA during endosomal escape. El 
Ouahabi et al., for example, demonstrated that the complexation of luciferase encoding mRNA by 
cationic lipids strongly reduced its accessibility to the translation machinery, with almost a complete 
loss of luciferase expression at w/w ratios over 4 in a cell-free translation system [52], indicating that 
only free mRNA is efficiently transcribed to GFP. Alternatively, a lower amount of expressed protein 
could result from a different stimulation of immune responses by the encapsulated mRNA or the 
amount of lipids present in the complexes. mRNA is known to be able to stimulate the endosomal toll-
like receptor 3 and 7/8 [2]. However, as the mRNA in complexes with v/w ratio 5 is expected to be less 
exposed on the outside of the lipoplexes, it seems less likely that complexes with v/w ratio 5 are more 
immune stimulatory than those with v/w ratio 3. Therefore, we assume that mainly the dissociation of 
mRNA is the factor that determines the better transfection efficiency of lipoplexes with v/w ratio 3. 
Interestingly, the cellular internalization of complexes and the resulting transfection efficiency did not 
lower significantly after the pre-incubation of lipoplexes with biological fluids such as human serum 
(P=0.6987) and ascitic fluid (P=0.989) (Figure 8 A-D, compared to Figure 7A-D). Therefore, 
messengerMAX/mRNA complexes with v/w ratio 3 seem good candidates for in vivo delivery of mRNA 
as well.   
Apart from lipid-based carriers, polyplexes of linPEI/mRNA were prepared with increasing N/P ratios. 
From gel electrophoresis, full complexation was observed from N/P ratio of 3 (Figure 3). However, 
from FCS measurements, an “apparent decrease in complexation efficiency” was found for 
linPEI/mRNA at higher N/P ratios. An explanation for this apparent decomplexation can be found when 
looking at the fluorescence fluctuation profiles. In contrast to lipid-based complexes, no fluorescent 
peaks appeared in the fluorescence fluctuation profiles when using linear PEI polymers at N/P ratio 3. 
As gel electrophoresis demonstrated that all mRNA was bound into polyplexes at these N/P ratios, the 
absence of fluorescence peaks indicates that the complexed Cy5 labeled mRNA is quenched, rendering 
the complexes invisible for the FCS instrument. This quenching typically occurs when the fluorescent 
labels on the complexed nucleic acids are tightly packed together in the polyplexes’ core, and was 
observed before for oligonucleotides as well [50]. With higher N/P ratios, the fluorescence fluctuation 
profiles changed as fluorescence peaks occurred and a gradual increase in the fluorescence baseline 
was observed. Both phenomena point to a gradual dequenching as the fluorescently labeled mRNA 
distributes differently over PEI complexes at a higher N/P ratio. For PEI complexes containing more 
than one fluorescently labeled mRNA molecule, dequenching results in the appearance of fluorescence 
peaks. Dequenching, however also results in the increase of the fluorescence baseline as more mono-
molecular complexes are formed, containing a single fluorescently labeled mRNA per complex. As the 
PEI polymers themselves are not fluorescently labeled, these mono-molecular complexes are 
misinterpreted as released free mRNA.  
When PEI complexes were incubated with biofluids, gel electrophoresis was no longer suitable to 
measure the association or dissociation degree (Figure 6B). Using FCS, however, it was observed that 
linPEI/mRNA complexes with an intermediate N/P ratio of 5 release up to 50% and 80% of the 
complexed mRNA in the presence of human serum and human ascitic fluid respectively (Figure 6D). 
Increasing the N/P ratio make polyplexes more stable in the presence of biofluids (Figure 6D). 
Nevertheless, we observed that cellular uptake of both linPEI/mRNA polyplexes with N/P 5 and 10 was 
significantly reduced in the presence of human serum (N/P 5, P=0.032, *; N/P 10, P=0.0368) and human 
ascitic fluid (N/P 5, P=0.0186, *; N/P 10, P=0.0022) (Figure 8G, H, Cy5). This decrease in cellular uptake 
most likely results from the presence of proteins in the biofluids that induce the premature release of 
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mRNA in the extracellular environment and might additionally form a protein corona around the 
polyplexes, preventing their cellular uptake.  
When compared to mRNA lipoplexes, we observed that less mRNA polyplexes were delivered per cell 
(Figure 7), which is in agreement with previous studies [19]. We also observed, however, that only a 
very limited amount of GFP expression was detected per cell in the presence of biofluids (Figure 8F, H, 
GFP). This phenomena was surprising based on previous research that DNA-containing polyplexes had 
higher or comparable gene expression than lipid transfection agents and did not reveal serum 
dependence [53]. PEI with varying molecular weights and forms have been extensively investigated for 
transfection efficiency and cytotoxicity. It has been reported that the release of nucleic acids such as 
mRNA may be impaired in these PEI-based complexes [25][54][55]. Also we observed that the MFI of 
GFP expression was much less when compared to messengerMAX/mRNA complexes, with a MFI of 
maximum 200 for linPEI/mRNA with N/P ratio 5 when compared to about 5500 for 
messengerMAX/mRNA complexes with v/w ratio 3 (Figure 7B, E, GFP). It is known that after cellular 
uptake through endocytosis, PEI polyplexes escape the endosomes by the “proton sponge” effect. The 
buffering effect of PEI evokes the continuous proton influx in the endosomes, which induces osmotic 
swelling and rupture resulting in release of the complexed cargo and/or intact polyplexes into the 
cytoplasm of the cells [25][56]. Once released into the cytosol, polyplexes should dissociate before 
nucleic acids like mRNA can be translated into the encoded proteins. Based on our observations, this 
endosomal escape and/or dissociation of the mRNA into the cytosol does not occur for linPEI 
complexes as no mRNA is detected in the cytoplasm of the cells (Supplementary Figure 4). 
Furthermore, linPEI/mRNA complexes did not dissociate in the presence of cell lysate (Figure 6). Also 
others have observed that the dissociation of polyplexes in the cytoplasm seems relatively slow [57]. 
For example, the intracellular polyplexes of double-labeled PEI/DNA were not dissociated yet after 4 h 
incubation with B16F10 cells [58], while dissociation of these polyplexes was found after incubated 
with pancreatic carcinoma cells for 18 h [59]. The mechanisms of polyplexes’ dissociation is still poorly 
understood even though dissociation of free nucleic acids in the cytoplasm of the cells is required for 
efficient transfection. Rejman J et al. [19] investigated the endosomal release of linear PEI (22 
kDa)/mRNA encoding GFP by using photochemical internalization (PCI) to trigger an oxidative process 
that leads to disruption of the endosomal membrane and release of material localized in this 
compartment. The PCI-induced release of polyplexes from the endosomal compartment did not 
enhance transfection mediated by these complexes, suggesting that especially the dissociation of the 
mRNA from the polymer may impede its potential in gene delivery. Furtherly, Bettinger T et al. [13] 
observed that the amount of GFP-positive cells (%) for PEI 25 kDa/mRNA complexes was 0%, compared 
to 82% for PEI 25 kDa/mRNA in the presence of pAsp, indicating that the induced dissociation of mRNA 
from the complexes by pAsp made more mRNA available for translation. To address the problem of 
too strong mRNA binding by PEI, several strategies have been envisaged to favor dissociation of 
polyplexes in the cytoplasm without compromising the extracellular stability. For example, reducible 
PLL polymers, which can be degraded in the cells and then facilitate DNA release, were developed and 
permitted up to 187-fold increase in gene expression [60]. Also, reducible BPEI1.2k-SS complexes were 
developed to efficiently deliver the siRNA by enhancing the dissociation free siRNA in the cytoplasm 
without compromising of complexes’ stability [61]. The FCS method proposed in this study is ideally 
suited to determine the optimal complexation efficiency and stability in the extracellular environment 
that still allows for good internalization, endosomal escape and release of mRNA into the cytoplasm of 
the cells. Considering the recently reported poor correlation between the in vitro and in vivo delivery 
of nucleic acids, screening the stability of complexes in extracellular fluids is becoming increasingly 
important [62]. Furthermore, as demonstrated before for small oligonucleotides, the FCS can also be 
applied in dual-color mode, where both the nucleic acids and the carrier are labeled with two distinct 
fluorophores [47][63]. Also for mRNA, dual-color FCS is expected to allow us to furtherly investigate 
the intracellular dissociation of mRNA from its carrier.    
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5. Conclusion 
In this study, we tested the stability of different mRNA-based formulations in HEPES buffer, human 
serum and human ascitic fluid, as well as the uptake, transfection and cytotoxicity in SKOV-3 cells. We 
found that FCS is feasible to follow the association/dissociation degree (%) of mRNA complexes both 
in buffer and biological fluids in a few minutes, which is a major advantage over typical gel 
electrophoresis. Gel electrophoresis is not only more time-consuming, making it not suitable for 
monitoring the time-dependent dissociation of mRNA-carrier complexes on the short time scale (e.g. 
within minutes), it also does not allow to detect intact dissociated mRNA in the presence of biological 
fluids such as full human serum and human ascitic fluid. We found that mRNA is more strongly bound 
to PEI-based complexes, leading to quenching of mRNA fluorescence and difficulty to dissociate the 
mRNA from the complexes in the intracellular environment. This led to very low transfection 
efficiencies in SKOV-3 cells as the complexed mRNA is not translated into GFP proteins. For lipid-based 
complexes, the dissociation of mRNA from the carriers with an intermediate complexation ratio 
resulted in efficient release of mRNA into the cytoplasm of the cells. Furthermore, lipoplexes used in 
this study were not sensitive to pre-incubation in biological fluids, while the already low efficiency of 
PEI-based complexes dropped even further in the presence of biofluids. Taken together, our data 
demonstrate that it is useful to screen complex stability in extracellular fluids and that we should 
maintain a critical balance between extracellular stability (in undiluted biofluids) and intracellular 
cargo release for optimization of nanoparticles formulations.  
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 Figures:  
 
Figure 1. (A) Fluorescence fluctuations of naked Cy5 labeled mRNA recorded by FCS in 
function of time. (B) Fluorescence profile of mRNA-lipoplexes or mRNA-polyplexes measured 
by FCS. The high fluorescence peaks are the complexes containing multiple fluorescent 
mRNA molecules, while the fluorescence signal between peaks is the naked fluorescent 
mRNA. (C) Calculation of association/dissociation degree (%) of mRNA complexes.  
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Figure 2. Association degree (%) of messengerMAX/mRNA, prepared at different v/w ratios, 
in HEPES buffer. (A) Representative gel for naked and complexed mRNA with v/w ratios as 
depicted above the gel. The star indicates the level of naked mRNA in the gel, while the arrow 
shows the v/w ratio from which full complexation starts. (B, D) Representative fluorescence 
fluctuations as measured with FCS for naked mRNA (red) and messengerMAX/mRNA 
complexes with v/w ratio 3 (blue) and 10 (green) respectively. (C) shows the association 
degree (%) calculated from 3 independent FCS (gray bars) and gel (dark gray bars) 
measurements.  
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Figure 3. Association degree (%) of linPEI/mRNA, prepared at different N/P ratios, in HEPES 
buffer. (A) Representative gel for naked and complexed mRNA with N/P ratios as depicted 
above the gel. The star indicates the level of naked mRNA in the gel, while the arrow shows 
the N/P ratio from which full complexation starts. (B, D) Representative fluorescence 
fluctuations as measured with FCS for naked mRNA (red) and linPEI/mRNA complexes with 
N/P ratio 3 (blue) and 15 (green) respectively. (C) shows the association degree (%) calculated 
from 3 independent FCS (gray bars) and gel (dark gray bars) measurements. 
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Figure 4. Dissociation degree (%) of messengerMAX/mRNA (v/w ratio 3) induced by SDS in 
HEPES buffer. (A)  Representative gel for naked and complexed mRNA with increasing amounts 
of SDS as depicted above the gel. The star indicates the level of naked mRNA in the gel. (B, D) 
Representative fluorescence fluctuations as measured with FCS for naked mRNA (red) and 
messengerMAX/mRNA complexes before (grey) and after addition of 4 µg SDS (blue) and 10 
µg SDS (green) respectively. (C) shows the association degree (%) calculated from 3 
independent FCS (gray bars) and gel (dark gray bars) measurements. (P<0.0001,****) 
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Figure 5. Dissociation degree (%) of linPEI/mRNA (N/P ratio 5) induced by DS in HEPES buffer. 
(A)  Representative gel for naked and complexed mRNA with increasing amounts of DS as 
depicted above the gel. The star indicates the level of naked mRNA in the gel. (B, D) 
Representative fluorescence fluctuations as measured with FCS for naked mRNA (red) and 
linPEI/mRNA complexes before (grey) and after addition of 5 µg DS (blue) and 150 µg DS 
(green) respectively. (C) shows the association degree calculated from 3 independent FCS 
(gray bars) and gel (dark gray bars) measurements. (P<0.05, *; P<0.001, **) 
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Figure 6. Stability of messengerMAX/mRNA with v/w ratio of 1 (black bars), 3 (gray bars) and 
5 (dark gray bars) and linPEI/mRNA with N/P ratio of 1 (black bars), 5 (gray bars) and 10 (dark 
gray bars) in HEPES buffer, 80 vol% biological fluids (human serum and human ascitic fluid) 
and 80 vol% cell lysate after incubation at 37°C for 1 h by 1% agarose gel electrophoresis (A, 
B) and corresponding dissociation degree (%) as calculated from three independent FCS 
measurements (C, D). The star indicates the level of naked mRNA in HEPES buffer in the gel.  
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Figure 7. Uptake and transfection efficiency of (A-C) messengerMAX/mRNA with v/w ratio 1 
(black bars), 3 (gray bars) and 5 (dark gray bars) and (D-F) linPEI/mRNA with N/P ratio 1 (black 
bars), 5 (gray bars) and 10 (dark gray bars) after incubation in Opti-MEM for 1 h. (A, D) 
Percentage of Cy5 and GFP positive cells after 4 h and 24 h incubation at 37°C, respectively. 
(B, E) MFI of Cy5 and GFP positive cells after 4 h and 24 h incubation at 37°C, respectively. All 
the data are averaged from 3 independent flow cytometry measurements. Images of SKOV-3 
cells transfected with (C) messengerMAX/mRNA (v/w of 3) and (F) linPEI/mRNA (N/P of 5) 
after incubation in Opti-MEM at 37°C for 24 h. Cy5: red fluorescence; GFP: green fluorescence. 
Scale bar: 33 μm.  
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Figure 8.  Uptake and transfection efficiency of (A-D) messengerMAX/mRNA with v/w ratio 1 
(black bars), 3 (gray bars) and 5 (dark gray bars) and (E-H) linPEI/mRNA with N/P ratio 1 (black 
bars), 5 (gray bars) and 10 (dark gray bars) after incubation in human serum and human ascitic 
fluid for 1 h at 37°C. (A, C, E, G) Percentage and (B, D, F, H) MFI of Cy5 positive cells (after 4 h 
incubation at 37°C) and GFP expressing cells (after 24 h incubation at 37°C). All the data are 
averaged from 3 independent flow cytometry measurements.  
 
Supplementary figures 
 
Supplementary Figure 1. Characteristics of (A, B) messengerMAX/mRNA with varying v/w 
ratios (C, D) linPEI/mRNA with varying N/P ratios in HEPES buffer. All the data are averaged 
from 3 independent DLS measurements.  
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Supplementary Figure 2. Fluorescence fluctuations of Cy5-mRNA recorded by FCS, after 
incubation in HEPES buffer (gray), undiluted human serum (red), undiluted ascitic fluid (green) 
and cell lysate (blue) at 37°C for 1 h. Mean fluorescence of Cy5 in human serum, ascitic fluid 
and cell lysate was around 3 times that of HEPES buffer, due to the degradation of mRNA 
observed on gel (Figure 6A and 6B).  
 
 
Supplementary Figure 3. Cell viability of (A) messengerMAX (gray bars) and 
messengerMAX/mRNA (dark gray bars) with v/w ratio 1, 3 and 5 and (B) linPEI (gray bars) and 
linPEI/mRNA (dark gray bars) with N/P ratio 1, 5 and 10 after incubation in Opti-MEM for 4 h 
at 37°C. To avoid interference of fluorescence from Cy5 with the MTT read-out, non-labeled 
mRNA with exactly the same modification was complexed into lipoplexes and polyplexes. All 
the data are averaged from 3 independent measurements.  
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Supplementary Figure 4. Mean fluorescence intensity of (A) Cy5 and (B) GFP as detected by 
FCS in the cytoplasm of SKOV-3 cells after 4 h incubation with messengerMAX/mRNA (v/w 3) 
and linPEI/mRNA (N/P 5) in Opti-MEM at 37°C. All the data are averaged from 3 independent 
FCS measurements. 
 
 
 
